111 Long-term Debt / Capital 2018-2025 | YI
111 long-term debt / capital from 2018 to 2025. Long-term debt / capital can be defined as a measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.066B | $1.973B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.919B | 58.42 |
| Doximity (DOCS) | United States | $11.317B | 52.39 |
| Hims & Hers Health (HIMS) | United States | $10.654B | 110.70 |
| Tempus AI (TEM) | United States | $10.042B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.327B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.691B | 57.67 |
| Hinge Health (HNGE) | United States | $3.687B | 0.00 |
| Privia Health (PRVA) | United States | $2.458B | 168.00 |
| Schrodinger (SDGR) | United States | $1.674B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.583B | 0.00 |
| Phreesia (PHR) | United States | $1.580B | 0.00 |
| Enovis (ENOV) | United States | $1.502B | 8.38 |
| Azenta (AZTA) | United States | $1.434B | 66.64 |
| 10x Genomics (TXG) | United States | $1.421B | 0.00 |
| Omnicell (OMCL) | United States | $1.313B | 23.17 |
| Evolent Health (EVH) | United States | $1.146B | 97.60 |
| Claritev (CTEV) | United States | $0.705B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.540B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Standard BioTools (LAB) | United States | $0.479B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.465B | 0.00 |
| Talkspace (TALK) | United States | $0.427B | 127.50 |
| TruBridge (TBRG) | United States | $0.337B | 746.67 |
| Outset Medical (OM) | United States | $0.310B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.270B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.269B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| CapsoVision (CV) | United States | $0.206B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.187B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.160B | 0.00 |
| Pulmonx (LUNG) | United States | $0.128B | 0.00 |
| American Well (AMWL) | United States | $0.125B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.115B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.087B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.027B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |